Share chart Affymax Inc.
Extended chart
Simple chart
About
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
IPO date |
2006-12-15 |
ISIN |
US00826A1097 |
Industry |
Biotechnology |
Sector |
Health Care |
Валюта |
usd |
Валюта отчета |
usd |
Сайт |
https://www.affymax.com
|
Change price per day: |
0% (0.0008) |
Change price per week: |
0% (0.0008) |
Change price per month: |
0% (0.0008) |
Change price per 3 month: |
+14.29% (0.0007) |
Change price per half year: |
-61.9% (0.0021) |
Change price per year: |
+33.33% (0.0006) |
Change price per 3 year: |
-99.63% (0.219) |
Change price per 5 year: |
-94.29% (0.014) |
Change price per 10 year: |
0% (0.0008) |
Change price per year to date: |
0% (0.0008) |
|
Underestimation
Title |
Value |
Grade |
P/S |
0 |
0 |
P/BV |
0 |
0 |
P/E |
0 |
0 |
EV/EBITDA |
0 |
0 |
Total: |
|
2.5 |
|
Efficiency
Title |
Value |
Grade |
ROA, % |
0 |
0 |
ROE, % |
0 |
0 |
Total: |
|
0 |
|
|
Dividends
Title |
Value |
Grade |
Div yield, % |
0 |
0 |
DSI |
0.5 |
5 |
Total: |
|
2.35 |
|
Debt
Title |
Value |
Grade |
Debt/EBITDA |
0 |
10 |
Total: |
|
10 |
|
Growth impulse
Title |
Value |
Grade |
Yield Revenue, % |
-98.81 |
0 |
Yield Ebitda, % |
-50.89 |
0 |
Yield EPS, % |
-131 |
0 |
Total: |
|
0 |
|
Head |
Job title |
Payment |
Year of birth |
Mr. Mark G. Thompson |
CFO & Secretary |
|
1962 (63 years) |
Mr. Jonathan M. Couchman |
CEO, President & Director |
|
1970 (55 years) |
Dr. Tracy J. Dunn Ph.D., J.D. |
Vice President of Intellectual Property & Legal Affairs |
|
1963 (62 years) |